FDA rejects AZ lung disease treatment
AstraZeneca announced that the FDA has rejected its new drug application for a chronic obstructive pulmonary disease (COPD) therapy.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news